(Q45158976)

10 December 2017

title

5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe liver dysfunction (English)

1 reference

10 December 2017

1 reference

metastatic colon cancer

1 reference

1 reference

1 reference

Marwan G Fakih

1

1 reference

10 December 2017

publication date

1 January 2004

1 reference

10 December 2017

1 reference

10 December 2017

volume

67

1 reference

10 December 2017

issue

3-4

1 reference

10 December 2017

page(s)

222-224

1 reference

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

10 December 2017

cites work

1 reference

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

21 January 2018

1 reference

Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunction.

21 January 2018

1 reference

Dosage adjustment and pharmacokinetic profile of irinotecan in cancer patients with hepatic dysfunction

21 January 2018

1 reference

A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000081321

1 reference

10 December 2017

1 reference